University Medical Center of Southern Nevada is a non-profit government hospital in Las Vegas, Nevada. It is the only government run hospital owned and operated by the Clark County Commission.

There are 564 (2010) beds in University Medical Center of Southern Nevada.

During the past decade, University Medical Center of Southern Nevada conducted 169 clinical trials. In the 10-year time frame, 169 clinical trials started and 150 clinical trials were completed, i.e. on average, 88.8% percent of trials that started reached the finish line to date. In the past 5 years, 58 clinical trials started and 77 clinical trials were completed. i.e. 132.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Medical Center of Southern Nevada" #1 sponsor was "National Cancer Institute (NCI)" with 129 trials, followed by "Alliance for Clinical Trials in Oncology" with 62 trials sponsored, "Children's Oncology Group" with 46 trials sponsored, "SWOG Cancer Research Network" with 40 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 40 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 32 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Medical Center of Southern Nevada" #1 collaborator was "National Cancer Institute (NCI)" with 195 trials as a collaborator, "NRG Oncology" with 13 trials as a collaborator, "SWOG Cancer Research Network" with 12 trials as a collaborator, "NCIC Clinical Trials Group" with 11 trials as a collaborator and "Canadian Cancer Trials Group" with 10 trials as a collaborator. Other collaborators include 73 different institutions and companies that were collaborators in the rest 44 trials.

According to Clinical.Site data, the most researched conditions in "University Medical Center of Southern Nevada" are "Breast Cancer" (23 trials), "Lung Cancer" (13 trials), "Recurrent Neuroblastoma" (13 trials), "Prostate Cancer" (12 trials) and "Refractory Neuroblastoma" (12 trials). Many other conditions were trialed in "University Medical Center of Southern Nevada" in a lesser frequency.

Most popular intervention types in "University Medical Center of Southern Nevada" are "Drug" (263 trials), "Other" (195 trials), "Biological" (113 trials), "Procedure" (74 trials) and "Radiation" (49 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (99 trials), "Quality-of-Life Assessment" (55 trials), "Questionnaire Administration" (42 trials), "Biospecimen Collection" (34 trials) and "Computed Tomography" (33 trials). Other intervention names were less common.

The vast majority of trials in "University Medical Center of Southern Nevada" are 301 trials for "All" genders, 39 trials for "Female" genders and 13 trials for "Male" genders.

Currently, there are NaN active trials in "University Medical Center of Southern Nevada". undefined are not yet recruiting, 71 are recruiting, 134 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 124 completed trials in University Medical Center of Southern Nevada, 5 suspended trials, and 16 terminated clinical trials to date.

Out of the total trials that were conducted in University Medical Center of Southern Nevada, 5 "Phase 1" clinical trials were conducted, 143 "Phase 2" clinical trials and 158 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 14 trials that are defined as “Not Applicable".